Создание и сравнител ьный анализ химерных антигенных рецепторов, специфичных к CD20; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
| Parent link: | Перспективы развития фундаментальных наук=Prospects of Fundamental Sciences Development: сборник научных трудов XIV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 25-28 апреля 2017 г./ Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой.— , 2017 Т. 4 : Биология и фундаментальная медицина.— 2017.— [С. 22-24] |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | |
| Zusammenfassung: | Заглавие с экрана Despite many advances in target therapies, survival of patients with rALL remains dismal, particularly among adults. Nonetheless, adoptive transfer of T-cells expressing chimeric antigen receptors (CARs) specific for the surface B cell molecule CD19 has been shown to be highly successful, as 50-90% of rALL patients receiving this therapy have achieved spectacular and durable remissions. This has inspired several research groups to develop CARs recognizing alternative B-cell targets, such as CD20, CD22, and BCMA, so as to use them in patients with other B-cell malignancies or help the patients that are unlikely to respond to CD19CAR T-cell therapy. Currently, there are two CD20-specific CARs in clinical trials. These CARs are based on the sequences of murine monoclonal antibodies Leu16 and 1F5 and use distinct hinge, transmembrane and signaling modules. Although both of these CARs appear to work, their side-by-side comparisons or structural optimization have never been performed in vitro or in vivo. The goal of our project was to design a CD20-specific CAR based on the human monoclonal antibody 2F2 (ofatumumab) and to compare this CAR to Leu16- and 1F5-based CARs in a unified context. |
| Sprache: | Russisch |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online-Zugang: | http://earchive.tpu.ru/handle/11683/44878 |
| Format: | Elektronisch Buchkapitel |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=624959 |
MARC
| LEADER | 00000naa2a2200000 4500 | ||
|---|---|---|---|
| 001 | 624959 | ||
| 005 | 20231101133335.0 | ||
| 035 | |a (RuTPU)RU\TPU\conf\24219 | ||
| 035 | |a RU\TPU\conf\24215 | ||
| 090 | |a 624959 | ||
| 100 | |a 20171205d2017 k y0rusy50 ca | ||
| 101 | 0 | |a rus |d eng | |
| 102 | |a RU | ||
| 105 | |a y z 100zy | ||
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Создание и сравнител ьный анализ химерных антигенных рецепторов, специфичных к CD20 |d Design and comparative analysis of cd20-specific chimeric antigen receptors |f Т. Н. Беловежец |g науч. рук. А. А. Горчаков | |
| 203 | |a Текст |c электронный | ||
| 230 | |a 1 компьютерный файл (pdf; 156 Kb) | ||
| 300 | |a Заглавие с экрана | ||
| 330 | |a Despite many advances in target therapies, survival of patients with rALL remains dismal, particularly among adults. Nonetheless, adoptive transfer of T-cells expressing chimeric antigen receptors (CARs) specific for the surface B cell molecule CD19 has been shown to be highly successful, as 50-90% of rALL patients receiving this therapy have achieved spectacular and durable remissions. This has inspired several research groups to develop CARs recognizing alternative B-cell targets, such as CD20, CD22, and BCMA, so as to use them in patients with other B-cell malignancies or help the patients that are unlikely to respond to CD19CAR T-cell therapy. Currently, there are two CD20-specific CARs in clinical trials. These CARs are based on the sequences of murine monoclonal antibodies Leu16 and 1F5 and use distinct hinge, transmembrane and signaling modules. Although both of these CARs appear to work, their side-by-side comparisons or structural optimization have never been performed in vitro or in vivo. The goal of our project was to design a CD20-specific CAR based on the human monoclonal antibody 2F2 (ofatumumab) and to compare this CAR to Leu16- and 1F5-based CARs in a unified context. | ||
| 461 | 1 | |0 (RuTPU)RU\TPU\conf\21388 |t Перспективы развития фундаментальных наук |l Prospects of Fundamental Sciences Development |o сборник научных трудов XIV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 25-28 апреля 2017 г. |o в 7 т. |f Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой |d 2017 | |
| 463 | 1 | |0 (RuTPU)RU\TPU\conf\21393 |t Т. 4 : Биология и фундаментальная медицина |v [С. 22-24] |d 2017 | |
| 510 | 1 | |a Design and comparative analysis of cd20-specific chimeric antigen receptors |z eng | |
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a эксперименты | |
| 610 | 1 | |a модули | |
| 610 | 1 | |a трансдукция | |
| 610 | 1 | |a клетки | |
| 610 | 1 | |a инкубация | |
| 700 | 1 | |a Беловежец |b Т. Н. | |
| 702 | 1 | |a Горчаков |b А. А. |4 727 | |
| 801 | 2 | |a RU |b 63413507 |c 20171211 |g RCR | |
| 856 | 4 | |u http://earchive.tpu.ru/handle/11683/44878 | |
| 942 | |c BK | ||